Organigram Global Inc

Organigram Global Inc(OGI)财务数据

$0.930

-0.034 (-3.65%)收盘时

OGI 盈利能力与利润率

Evaluating the bottom line, Organigram Global Inc maintains a gross margin of 23.06%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -11.06%, while the net margin is 99.77%. These profitability ratios, combined with a Return on Equity (ROE) of 19.89%, provide a clear picture of how effectively OGI converts its operational activities into shareholder value.

OGI 同业对比

In the context of the broader market, OGI competes directly with industry leaders such as LMNR and GLAS. With a market capitalization of $134.03M, it holds a significant position in the sector. When comparing efficiency, OGI's gross margin of 23.06% stands against LMNR's 12.60% and GLAS's 26.22%. Such benchmarking helps identify whether Organigram Global Inc is trading at a premium or discount relative to its financial performance.

Organigram Global Inc 财务表现

OrganiGram's financial performance has been mixed, with a notable recovery in Q3 2026 where net revenue reached $105.8 million, a 49% year-over-year increase, and a gross margin of 23.06%. This indicates a strong rebound from previous declines.

Financials

FY2026Q3
YoY:
+49.43%
105.78M
Total Revenue
FY2026Q3
YoY:
-42.33%
-11.70M
Operating Profit
FY2026Q3
YoY:
-1776.80%
105.54M
Net Income after Tax
FY2026Q3
YoY:
-1640.00%
0.77
EPS - Diluted
FY2026Q3
YoY:
-197.21%
-4.83M
Free Cash Flow
FY2026Q3
YoY:
+104.98%
23.06
Gross Profit Margin - %
FY2026Q3
YoY:
+29.06%
-9.77
FCF Margin - %
FY2026Q3
YoY:
-1222.27%
99.77
Net Margin - %

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易